Can a pharmacy become USP <797> compliant simply by purchasing a compounding aseptic isolator(s) or CAI?
Isolators alone will not ensure compliance with USP <797>. Using an isolator for sterile compounding addresses only part of the requirements for USP <797>. Issues such as process validation, training, BUD determination, product quality maintenance after the CSP (compounded sterile product) leaves the pharmacy, caregiver training, patient monitoring, QA program, etc. remain the same as for products compounded in standard laminar flow hoods.
Isolators alone will not ensure compliance with USP <797>. Using an isolator for sterile compounding addresses only part of the requirements for USP <797>. Issues such as process validation, training, BUD determination, product quality maintenance after the CSP (compounded sterile preparation) leaves the pharmacy, caregiver training, patient monitoring, QA program, etc. remain the same as for products compounded in standard laminar flow hoods.
Related Questions
- Are Barrier Isolators / Isolators / Compounding Aseptic Isolators CAI/CACI compliant with the USP 797 revision?
- What are the requirements for using a Compounding Aseptic Containment Isolator (CACI), for Hazardous Drugs?
- Can a pharmacy become USP <797> compliant simply by purchasing a compounding aseptic isolator(s) or CAI?